PSA Standardization
Reasons for Ordering PSA1
October 2009
One study closely examined the reasons physicians were ordering PSA tests. As clearly shown in the graph, a majority of orders were for prostate cancer screening, followed by monitoring cancer reoccurrence, following suspected cancers, monitoring patient’s cancer progression, and less often used in managing BPH. Although this study was published nearly one decade ago, similar practices are observed in clinics and medical facilities across the country and PSA testing is often the highest volume tumor marker laboratories perform.
Reasons for Ordering PSA1 |
Jump to section:
- Introduction
- Elevated PSA Result on Screening
- Reasons for Ordering PSA1
- PSA Screening in the News
- Recommendations for Screening
- Arguments for Screening for Prostate Cancer
- Recommendations for Not Screening
- Arguments Against Screening for Prostate Cancer
- PSA Sensitivity and Specificity
- High-Grade Prostate Cancer is Not Rare When PSA =4.0 ng/mL6
- Increase Specificity Using PSA Velocity8
- Optimizing Clinical Sensitivity and Specificity: Age/Ethnic Reference Intervals9,10
- Utilization of Free/Total PSA Ratio11
- Why Aren't PSA Results Interchangeable?
- Development of PSA Standards
- Development of PSA Standards
- Effect of Analytical Bias on Classification Based on Fixed Criteria
- Analytical Difference: Results per 1000 Patients Tested13
- Hybritech vs. WHO Standardized Assays12,14
- Analytical Differences15
- CAP Proficiency Testing
- WHO 96/670 Total PSA Preparations16
- WHO Calibration/Concordance at 3.1 ng/mL Cutoff5
- WHO Calibration/Concordance at 3.1 ng/mL Cutoff5
- WHO Calibration/Concordance at 4.0 ng/mL Cutoff5
- Clinical Differences in PSA Screening14
- The Clinical Difference
- Fixed Thresholds Produce Problems for Biopsy Recommendations
- Effect on "Watchful Waiting"
- Effect on "Watchful Waiting"
- Adding Biological Variability into the Mix
- Futures in Prostate Cancer Testing?
- PSA Testing at Mayo
- Conclusions
- References
- References
- Questions?


